论文部分内容阅读
目的:分析临床借助沙美特罗氟替卡松、孟鲁司特纳联合疗法治疗慢性支气管炎患者的效果。方法:将我院收治慢性支气管炎患者100例作为对象,行不同分组后借助不同疗法治疗,即:给予对照组沙美特罗氟替卡松疗法,研究组则于该基础上加用孟鲁司特纳疗法,评估总体效果。结果:研究组缓解率为96.0%(48/50),对照组80.0%(40/50),有区别(P<0.05);研究组预后肺功能指标改善程度高于对照组,P<0.05,有区别。结论:临床针对慢性支气管炎患者行沙美特罗氟替卡松结合孟鲁司特钠疗法作用突出,可改善病症,提高疗效,值得学习。
OBJECTIVE: To analyze the clinical efficacy of salmeterol fluticasone and montelukastina in the treatment of patients with chronic bronchitis. Methods: One hundred patients with chronic bronchitis admitted to our hospital were enrolled in this study. Patients in different groups were treated with different therapies, namely: Salmeterol and Fluticasone were given to the control group, and the study group was treated with montelukast , Assess the overall effect. Results: The remission rate was 96.0% (48/50) in the study group and 80.0% (40/50) in the control group (P <0.05). The prognosis of the study group was better than that of the control group in prognosis of lung function (P <0.05, There are differences. Conclusion: The clinical treatment of patients with chronic bronchitis salmeterol fluticasone combined with montelukast sodium therapy is outstanding, can improve the symptoms and improve the efficacy, it is worth learning.